BioReference provides employers with flexible program options for employee screening ELMWOOD PARK, N.J., May 13, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today launched the BioReference Employer Solution, a COVID-19 screening program that assists employers’ decisions about return-to-work policies. Test results play a critical role in the fight against COVID-19 by identifying […]
Search Results for: hair test
ELMWOOD PARK, N.J., May 13, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a strategic collaboration with the Westchester Medical Center Health Network (WMCHealth), a 1,700-bed healthcare system headquartered in Valhalla, New York, to provide full laboratory administrative services, laboratory operations, reference testing and outpatient laboratory services. WMCHealth has 10 hospitals […]
In partnership with NYC Health + Hospitals, BioReference is expanding access to COVID-19 antibody testing ELMWOOD PARK, N.J., May 8, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of COVID-19 antibody screening available to New York City residents in partnership with New York City Health and Hospital Corporation (NYC Health […]
NYC Press Office Appointment-only antibody testing will be offered in Morrisania, East New York, Upper Manhattan, Concord, and Long Island City beginning next week NEW YORK—Mayor Bill de Blasio today announced expanded antibody testing for New Yorkers. Through a partnership with BioReference labs, the City will conduct its own antibody survey at community testing sites in the five boroughs […]
ACLA Statement on COVID-19 Testing STATEMENT FROM ACLA PRESIDENT JULIE KHANI: “We appreciated the opportunity to meet with Vice President Pence and members of the White House’s Coronavirus Task Force this afternoon on the critical issues related to testing capacity. As an industry, clinical labs have taken steps to meet the growing demand for national […]
BioReference to Provide Diagnostic Test Services and Assist with Patient-Centered Data Analytics ELMWOOD PARK, NJ. (August 1, 2019) – BioReference Laboratories, Inc., one of the largest clinical laboratories in the United States, today announced it has been selected by The IPA Association of America (TIPAAA) as its preferred provider of laboratory services and to assist with data […]
BioReference to also assist with Patient-Centered Data Analytics to SOMOS Providers SOMOS, New York City’s Largest Multi-Cultural Physician-Led Network Selects BioReference as Preferred Provider for Diagnostic Testing MIAMI, FL., July 01, 2019 (GLOBE NEWSWIRE) — BioReference Laboratories, Inc., an OPKO Health (NASDAQ: OPK) company and one of the largest clinical laboratories in the United States, has been selected […]
ELMWOOD PARK, N.J., May 2, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new research from its prenatal and hereditary cancer assessment programs at the 2019 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting in Nashville, Tennessee from May 3-6. The […]
Executive chairman Dr. Cohen recently spoke with Dr. Oz and New York Times journalist, John Carreyrou, about attempting 70+ tests on a single drop of blood. BioReference Phlebotomy Training Specialist, June Daves, also appeared and drew 6 vials of Dr. Oz’s blood. In case you missed the appearance, you can view a clip from this […]
ELMWOOD PARK, NJ, April 22, 2019 – BioReference Laboratories Inc., an OPKO Health Company (NYSE:OPK), is pleased to announce it will gain preferred laboratory network provider status for UnitedHealthcare. The contract includes BioReference’s subsidiary GeneDx, a full service genetics laboratory. Learn about the UnitedHealthcare Preferred Lab Network here. “At BioReference we are committed to making […]